GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nobel Biocare Holding AG (OTCPK:NBHGF) » Definitions » EV-to-EBIT

Nobel Biocare Holding AG (Nobel Biocare Holding AG) EV-to-EBIT : 25.49 (As of Jun. 15, 2024)


View and export this data going back to . Start your Free Trial

What is Nobel Biocare Holding AG EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Nobel Biocare Holding AG's Enterprise Value is $2,235.1 Mil. Nobel Biocare Holding AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2013 was $87.7 Mil. Therefore, Nobel Biocare Holding AG's EV-to-EBIT for today is 25.49.

The historical rank and industry rank for Nobel Biocare Holding AG's EV-to-EBIT or its related term are showing as below:

NBHGF's EV-to-EBIT is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 19.47
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Nobel Biocare Holding AG's Enterprise Value for the quarter that ended in Dec. 2013 was $1,642.2 Mil. Nobel Biocare Holding AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2013 was $87.7 Mil. Nobel Biocare Holding AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2013 was 5.34%.


Nobel Biocare Holding AG EV-to-EBIT Historical Data

The historical data trend for Nobel Biocare Holding AG's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nobel Biocare Holding AG EV-to-EBIT Chart

Nobel Biocare Holding AG Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.29 14.48 14.81 10.70 20.34

Nobel Biocare Holding AG Semi-Annual Data
Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.29 14.48 14.81 10.70 20.34

Competitive Comparison of Nobel Biocare Holding AG's EV-to-EBIT

For the Medical Instruments & Supplies subindustry, Nobel Biocare Holding AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nobel Biocare Holding AG's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nobel Biocare Holding AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Nobel Biocare Holding AG's EV-to-EBIT falls into.



Nobel Biocare Holding AG EV-to-EBIT Calculation

Nobel Biocare Holding AG's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=2235.090/87.701
=25.49

Nobel Biocare Holding AG's current Enterprise Value is $2,235.1 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Nobel Biocare Holding AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2013 was $87.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nobel Biocare Holding AG  (OTCPK:NBHGF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Nobel Biocare Holding AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2013 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2013 ) =EBIT / Enterprise Value (Q: Dec. 2013 )
=87.701/1642.16945
=5.34 %

Nobel Biocare Holding AG's Enterprise Value for the quarter that ended in Dec. 2013 was $1,642.2 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Nobel Biocare Holding AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2013 was $87.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nobel Biocare Holding AG EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Nobel Biocare Holding AG's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Nobel Biocare Holding AG (Nobel Biocare Holding AG) Business Description

Traded in Other Exchanges
N/A
Address
Nobel Biocare Holding AG was founded in 2002 in Zurich,Switzerland. The Company offers dental implant systems, high-precision individualized prosthetics and CAD/CAM systems, diagnostics, treatment planning, guided surgery solutions and biomaterials. Its segments include Implant system products and Individualized products. Its geographical segments include United States, Japan, Switzerland, and Other Countries.

Nobel Biocare Holding AG (Nobel Biocare Holding AG) Headlines